Nathan Westcott
Director, LNP Discovery
Beam Therapeutics
Nathan Westcott is the director of LNP discovery at Beam focused on extrahepatic LNP delivery. He received his PhD in 2011 from the University of North Carolina at Chapel Hill in Chemistry while studying self-assembled monolayers of alkanethiolates on gold to model the extracellular matrix. During his postdoc at the Rockefeller University, he studied ADP-ribosylation using alkynylated adenosine. Previously, he worked at Repertoire Immune Medicines and was focused on developing liposomes as an ex vivo drug delivery vehicle for immune agonists.